Completed Studies

Study/Grant Prinicpal Investigator Program Director Funding Dates
An Open-label, Multicenter Study With Follow-up Evaluating the Safety and Efficacy of Varenicline Tartrate in Comparison to Transdermal Nicotine Patch for Smoking Cessation Lori Pbert  Susan Druker Pfizer, Inc. 2005-2006
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Multi-center Study with Follow-up Evaluating the Safety and Efficacy of Varenicline Tartrate (CP-526,555) in Comparison to Zyban® for Smoking Cessation Lori Pbert Susan Druker Pfizer, Inc. 2003-2005
Evaluation of a School Nurse-Delivered Tobacco Cessation Intervention for Adolescents Lori Pbert Susan Druker MDPH 2002-2004
Policy to Support Tobacco Treatment in Health Care Judith Ockene, Lori Pbert, Jane Zapka (Co-PIs) Denise Jolicoeur NIH CA86282 2000-2005
Provider and Peer Delivered Youth Smoking Intervention Lori Pbert Susan Druker NIH R01 CA80254 1999-2004
Developing and Testing New HEDIS Smoking Measures Lori Pbert, Jack Hollis, Susan Druker Nancy Vuckovic RWJF  1999-2000
A Multi-Center, Randomized, Parallel, Placebo-Controlled, One-Year Study of the Efficacy and Safety of Zyban Versus Placebo as Aids to Smoking Cessation Treatment in Adult Cigarette Smokers Previously Treated with Bupropion Lori Pbert Susan Druker Glaxo Wellcome 1999-2000
A Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Buspirone (15 mg and 30 mg) as an Aid in Smoking Cessation Lori Pbert Susan Druker Bristol-Meyers Squibb/PharmaNet 1999-2000
Smoking Intervention for Low-Income Pregnant Women Judith Ockene,
Lori Pbert (Co-PI)
Deb Bonollo NIH R01 HL51319 1996-2001